Drug Safety Strategies to De-Risk Compounds--an IBC conference. 4-6 August 2009, Boston, MA, USA.
The Drug Safety Strategies to De-Risk Compounds conference, held in Boston, included topics covering new developments in the field of drug safety. This conference report highlights selected presentations on the early prediction of hepatotoxicity, improvements in models of cardiovascular toxicity, the use of biomarkers in drug development, and computational approaches to drug safety predictions. Emerging technologies and drug safety models, as well as case studies of safety assessment advances, are also discussed.
Mattes
William
W
PharmPoint Consulting, 17014 Hersperger Lane, Poolesville, MD 20837, USA. wbmattes@gmail.com
D000818:Animals; D015415:Biomarkers / Q000378:metabolism; D001900:Boston; D019295:Computational Biology / Q000639:trends; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D008099:Liver / Q000187:drug effects; D011237:Predictive Value of Tests
D015415:Biomarkers